🆕 Newsmakers — 9:30a ET, 2026-06-23 — new since last alert

📰 NEW MARKET THEMES: • From Greenspan To Warsh, The Battle Over Fed Communication Returns Central bank communication has altered its position on a spectrum over the last 40 years. At one end sits the rigorous, transparent model: numerical inflation targets, published forecasts, regular press conferences, forward guidance about the likely path of rates, and sharing Fe… — forbes.com · 06/23 9:20a https://www.forbes.com/sites/petercohan/2026/06/23/from-greenspan-to-warsh-the-battle-over-fed-communication-returns/ • Alan Greenspan's Legacy Holds 5 Key Lessons For Fed Chair Kevin Warsh When Alan Greenspan was first sworn in as chair of the Federal Reserve in 1987, the internet had yet to penetrate most households, the United States and Russia were the two dominant global superpowers, and U.S. GDP (expressed in 2017 dollars) stood at $9.32 trillion. — forbes.com · 06/23 9:10a https://www.forbes.com/sites/harrykraemer/2026/06/23/alan-greenspans-legacy-holds-5-key-lessons-for-fed-chair-kevin-warsh/ • Billionaire investor Philippe Laffont: There will be a $10 trillion company in the future Philippe Laffont, Coatue Management founder and portfolio manager, joins 'Squawk Box' to discuss the state of the AI boom, AI power demand, SpaceX IPO, latest market trends, his thoughts on chip stocks, bitcoin, agentic AI, and more. — youtube.com · 06/23 8:58a https://www.youtube.com/watch?v=xCrvqmWCpHA • Stock investors expect the Fed to save them. But no ‘Warsh put' is coming — and the ‘Greenspan put' was a myth. Wall Street's belief in a central bank safety net misreads the dot-com crash. Alan Greenspan was following rules — not saving portfolios. — marketwatch.com · 06/23 8:58a https://www.marketwatch.com/story/stock-investors-expect-the-fed-to-save-them-but-no-warsh-put-is-coming-and-the-greenspan-put-was-a-myth-ed92e3d9 • Small Caps Are Outperforming The Technology Sector Small caps, especially value-oriented, are outperforming as earnings growth broadens beyond the Magnificent-7. The Russell 2000 has surpassed both the S&P 500 and Nasdaq 100 over the past year, signaling economic expansion strength. — seekingalpha.com · 06/23 8:54a https://seekingalpha.com/article/4916933-small-caps-are-outperforming-technology-sector

📈 NEW GAINERS:

1. GETY +90% $1.15 (482M cap) Getty Images stock is skyrocketing today thanks to a surprise deal with ChatGPT-maker OpenAI Shares in Getty Images Holdings, Inc. (NYSE: GETY) are surging in premarket trading this morning—up nearly a staggering 150% as of the time of this writing—after the stock photography giant announced an unexpected deal with ChatGPT-maker OpenAI. Here's what you need to know. — fastcompany.com · 06/22 2:05p https://www.fastcompany.com/91562788/getty-images-stock-price-skyrocketing-today-surprise-deal-with-openai

2. APGE +47% $132.55 (8.2B cap) Nova Minerals redomiciles to US as Alaska gold and antimony work accelerates Nova Minerals Corp (ASX:NVA, NYSE-A:NVA, FRA:QM30) has completed its redomicile to the United States and started key 2026 field work at its Estelle Gold and... — proactiveinvestors.com · 06/23 8:23a https://www.proactiveinvestors.com/companies/news/1094301/nova-minerals-redomiciles-to-us-as-alaska-gold-and-antimony-work-accelerates-1094301.html

3. CAST +22% $9.84 (327M cap) (no fresh news today — likely technical / low-coverage move)

4. ORKA +18% $85.38 (3.1B cap) (no fresh news today — likely technical / low-coverage move)

5. MGRT +17% $83.93 (1.2B cap) (no fresh news today — likely technical / low-coverage move)

6. WYFI +16% $44.77 (1.6B cap) (no fresh news today — likely technical / low-coverage move)

7. RGNX +16% $9.07 (462M cap) Regenxbio Gains Fresh Chance As FDA Reconsiders Gene Therapy Regenxbio Inc. (NASDAQ:RGNX) on Monday said it aligned with the Food and Drug Administration (FDA) regarding the next steps needed for a potential accelerated approval of Navsunli (RGX-121, clemidsogene lanparvovec). — benzinga.com · 06/22 9:23a https://www.benzinga.com/news/fda/26/06/60013411/regenxbio-gains-fresh-chance-as-fda-reconsiders-gene-therapy

8. BWIN +16% $23.52 (1.8B cap) The Baldwin Insurance Group (BWIN) Moves 16.8% Higher: Will This Strength Last? The Baldwin Insurance Group (BWIN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. — zacks.com · 06/22 12:06p https://www.zacks.com/stock/news/2941004/the-baldwin-insurance-group-bwin-moves-16-8-higher-will-this-strength-last?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_5%-2941004

9. MLTX +15% $22.16 (1.5B cap) MoonLake Immunotherapeutics: Label Upside Drives The Next Leg Higher MoonLake Immunotherapeutics is positioned for upside on differentiated efficacy and a large, underpenetrated hidradenitis suppurativa, or HS, market. Recent Phase 3 VELA data show sonelokimab achieves superior HiSCR75/100 response rates and meaningful patient-reported quality of… — seekingalpha.com · 06/23 8:58a https://seekingalpha.com/article/4916934-moonlake-immunotherapeutics-label-upside-drives-the-next-leg-higher

10. CGEM +15% $17.30 (1.0B cap) (no fresh news today — likely technical / low-coverage move)

11. HIVE +15% $4.90 (1.2B cap) HIVE Stock Surges After Groundbreaking AI Project In Paraguay HIVE Digital Technologies Ltd (NASDAQ:HIVE) shares are soaring Monday after the company announced the completion of its AI research initiative using its GPU cluster in Asunción, Paraguay, in partnership with Columbia University. Here's what you need to know. — benzinga.com · 06/22 1:44p https://www.benzinga.com/trading-ideas/movers/26/06/60025120/hive-stock-surges-after-groundbreaking-ai-project-in-paraguay

12. BHVN +14% $15.50 (1.6B cap) (no fresh news today — likely technical / low-coverage move)

— new items only (already-sent headlines filtered). Full list in the 10am/3pm digest.